Massachusetts Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-102,897
Closed -$3.73M 856
2019
Q4
$3.73M Sell
102,897
-11,121
-10% -$341K ﹤0.01% 662
2019
Q3
$3.1M Sell
114,018
-29,865
-21% -$772K ﹤0.01% 686
2019
Q2
$3.46M Buy
143,883
+20,047
+16% +$509K ﹤0.01% 686
2019
Q1
$3.27M Buy
123,836
+4,582
+4% +$109K ﹤0.01% 677
2018
Q4
$2.33M Buy
119,254
+9,282
+8% +$182K ﹤0.01% 695
2018
Q3
$2.15M Sell
109,972
-254
-0.2% -$4.83K ﹤0.01% 714
2018
Q2
$1.82M Buy
110,226
+15,098
+16% +$230K ﹤0.01% 721
2018
Q1
$1.35M Buy
95,128
+1,485
+2% +$21.9K ﹤0.01% 730
2017
Q4
$1.37M Buy
93,643
+13,136
+16% +$184K ﹤0.01% 726
2017
Q3
$1.02M Buy
+80,507
New +$1.02M ﹤0.01% 743
2017
Q2
Sell
-10,216
Closed -$151K 897
2017
Q1
$151K Buy
+10,216
New +$165K ﹤0.01% 837
2015
Q3
Sell
-457,703
Closed -$15.9M 916
2015
Q2
$15.9M Buy
+457,703
New +$14M 0.01% 561

Other funds holding HZNP

Massachusetts Financial Services's HZNP Position: Q1 2020 in Review

Massachusetts Financial Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2020, closing a stake of 102,897 shares — an estimated $3.73M sold.

Massachusetts Financial Services first reported a position in HZNP in Q2 2015 and held it in 12 quarters. The position peaked at $15.9M in Q2 2015. 295 funds tracked by Wall St. Rank hold HZNP as of Q1 2020.

  • Massachusetts Financial Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Massachusetts Financial Services sold 102,897 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2020, an estimated $3.73M.
  • Massachusetts Financial Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 12 quarters.
  • Massachusetts Financial Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15.9M in Q2 2015.
  • 295 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2020.

Based on Massachusetts Financial Services's 13F filing for Q1 2020, filed 14 May 2020.